“The paper explains the content, structure, activities and


“The paper explains the content, structure, activities and contribution of the capacity building component of the Horizon 2020 Initiative, a major undertaking supported by the EU Neighbourhood policy instrument. The Mediterranean environment is one of the richest and at the same time most vulnerable in the world. A staggering 80% of its pollution comes from land based sources: municipal waste, urban waste and water, and industrial emissions. In 2006, the European Mediterranean Environment Ministers meeting in Cairo committed themselves to a targeted de-pollution of the Mediterranean Sea by 2020, known as

the “Horizon 2020 Initiative”. Within this framework, the Horizon 2020 Capacity Building/Mediterranean Environment Programme (H2020 CB/MEP) is one of its three operational components (the other two include the investments GSK923295 Cytoskeletal Signaling inhibitor for pollution reduction infrastructures and pollution monitoring). It aims at supporting the implementation of the Horizon 2020 Initiative Road Map and Work Plan through a large number (similar to 140) of capacity building and awareness raising activities, while strengthening institutions on environmental mainstreaming and H2020 priority areas. Environmental mainstreaming acts as an umbrella under which the three H2020 priorities are developed horizontally, cross cutting all capacity building activities so as to facilitate and create the enabling environment

for the proper implementation, Selleck Liproxstatin-1 not only of the capacity building component of H2020 but also of the entire Initiative. It is expected that the H2020 CB/MEP will provide by the end of 2012 capacity building for an average of 200-300 persons per country, which means about 3500 individuals in the entire region.”
“Background -\n\nIn studies investigating foetal malformations associated with antiepileptic drug exposure during pregnancy, the common practice has been to assess the incidence and nature of

the malformations at, or soon Elafibranor manufacturer after, birth. The adequacy of this approach to determine the true incidence of the malformations has received little attention.\n\nAims of the study -\n\nTo compare the incidence and natures of the foetal malformations recognized by, or soon after, birth with similar data for malformations recognized in the first post-natal year.\n\nMethods -Analysis of data from the Australian Register of Antiepileptic Drugs in Pregnancy.\n\nResults -\n\nUp to 25% of the malformations recognized by the end of the first post-natal year had not been detected by, or soon after, birth. There was a tendency for the late-recognized malformations to differ from the early-recognized ones in relation to the body parts involved.\n\nConclusions -\n\nEarly assessment and delayed assessment of infants for the presence of foetal malformations are complementary, with the latter resulting in finding a higher incidence of malformations.

Comments are closed.